Adrian Bot

16.7k citations
145 papers · 4.5k · 1 hit paper · h-index 35

Impact in

  • Immunology top 1%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
    • Immune Response and Inflammation
  • Oncology top 1%
    • CAR-T cell therapy research

Papers in

    • Immunotherapy and Immune Responses 46
    • Immune Cell Function and Interaction 24
    • Immune Response and Inflammation 19
    • T-cell and B-cell Immunology 18
    • Biosimilars and Bioanalytical Methods 15
    • CAR-T cell therapy research 70
    • Cancer Immunotherapy and Biomarkers 14

Adrian Bot

138 papers receiving 4.4k citations

Adrian Bot's Hit Papers

Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma 2017 · 487 citations
4870+3+6Years since publication100200300400

Peers

Adrian Bot
Comparison fields: 5 of 110
  • Immunology 1.9k
  • Oncology 2.3k
  • Genetics 808
  • Immunology and Allergy 136
  • Pharmaceutical Science 132
Replace Bjarne Bogen with:
Bjarne Bogen Norway
Scott A. Hammond United States
Mary Hitt Canada
Ramon Arens Netherlands
A. Karolina Palucka United States
Wendy W. J. Unger Netherlands
Larry Ellingsworth United States
Mélissa Dullaers Belgium
Carlo Heirman Belgium
Alexander D. McLellan New Zealand
Adrian Bot relative to Bjarne Bogen Norway Bjarne Bogen's profile →
Citations per field
00.5×5.1×
Bjarne Bogen · 1×
Citations per year

Countries citing papers authored by Adrian Bot

Since Specialization
Citations

This map shows the geographic impact of Adrian Bot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian Bot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian Bot more than expected).

Fields of papers citing papers by Adrian Bot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrian Bot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian Bot. The network helps show where Adrian Bot may publish in the future.

Co-authors

The 25 scholars most cited alongside Adrian Bot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Adrian Bot Line = papers co-authored together Adrian Bot links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 145 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma
Hit paper breakdown →
2017487
2 2020285
3 2020242
4 2018230
5 2017207
6 1999165
7 2008159
8 2021134
9 1998126
10 2005111
11 201796
12 200086
13 200180
14 200375
15 201171
16 200869
17 202068
18 201166
19 200265
20 199763

About Adrian Bot

Adrian Bot is a scholar working on Immunology, Oncology, Molecular Biology, Epidemiology and Genetics, having authored 145 papers that have together received 4.5k indexed citations. Recurring topics across this work include CAR-T cell therapy research (70 papers), Immunotherapy and Immune Responses (46 papers), Immune Cell Function and Interaction (24 papers), Immune Response and Inflammation (19 papers), T-cell and B-cell Immunology (18 papers), Influenza Virus Research Studies (18 papers), Biosimilars and Bioanalytical Methods (15 papers) and Cancer Immunotherapy and Biomarkers (14 papers). The work is most often cited by research in Immunology (1.9k citations), Oncology (2.3k citations), Genetics (808 citations), Immunology and Allergy (136 citations) and Pharmaceutical Science (132 citations). Adrian Bot has collaborated with scholars based in United States, Switzerland and France. Frequent co-authors include Simona Bot, John M. Rossi, Constantin A. Bona, Daniel J. Smıth, Allen Xue, Sattva S. Neelapu, William Y. Go, Frederick L. Locke, Armin Ghobadi and James N. Kochenderfer. Their work appears in journals such as Journal of Clinical Oncology, Blood, Cancer Research, Journal of Immunotherapy and European Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact